NEW YORK (GenomeWeb) – 10X Genomics announced today that is has signed agreements with four companies to promote and sell several of its products in the Asia-Pacific region.
The genomics company said its agreement with MDxK will cover South Korea, its deal with Millennium Science will cover Australia and New Zealand, it will reach Southeast Asia through Research Instruments, and China through Star Research Technology. These partners will distribute and support 10X's Chromium platform, as well as associated products for long-range and single-cell genomic applications.
Financial terms of the deals were not disclosed.
"The Asia-Pacific region is experiencing significant growth across all areas of genomics, spurring demand for solutions that provide full sequence information and genomic analysis at single-cell resolution," said 10X CEO Serge Saxonov in a statement. "These partnerships represent an important step in the global commercial expansion of 10X, and working together, we will be able to better serve our customers' needs in the Asia-Pacific region."
The company's Chromium Genome and Exome products include phasing, structural variant analysis, de novo genome assembly, and remapping of difficult regions of the genome. The recently introduced Chromium Single Cell Solution also allows for analysis of dynamic transcription events from large numbers of individual cells.